ZINECARD Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Zinecard, and what generic alternatives are available?

Zinecard is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in ZINECARD is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zinecard

A generic version of ZINECARD was approved as dexrazoxane hydrochloride by HIKMA on September 28^th, 2004.

Subscribe

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ZINECARD?
What are the global sales for ZINECARD?
What is Average Wholesale Price for ZINECARD?

Summary for ZINECARD

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	100
Clinical Trials:	27
Patent Applications:	4,779
Drug Prices:	Drug price information for ZINECARD
What excipients (inactive ingredients) are in ZINECARD?	ZINECARD excipients list
DailyMed Link:	ZINECARD at DailyMed

Drug patent expirations by year for ZINECARD

Recent Clinical Trials for ZINECARD

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Andrew E. Place	Phase 1
Children's Cancer Research Fund	Phase 1
University of Colorado, Denver	Phase 1

See all ZINECARD clinical trials

US Patents and Regulatory Information for ZINECARD

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-001	May 26, 1995		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Pfizer	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-002	May 26, 1995		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ZINECARD

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-002	May 26, 1995	⤷ Subscribe	⤷ Subscribe
Pfizer	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-001	May 26, 1995	⤷ Subscribe	⤷ Subscribe
Pfizer	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-002	May 26, 1995	⤷ Subscribe	⤷ Subscribe
Pfizer	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-002	May 26, 1995	⤷ Subscribe	⤷ Subscribe
Pfizer	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-001	May 26, 1995	⤷ Subscribe	⤷ Subscribe
Pfizer	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-001	May 26, 1995	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ZINECARD

See the table below for patents covering ZINECARD around the world.

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Germany	1967027	BIS-(3,5-DIOXOPIPERAZINO)-ALKANVERBINDUNGEN UND VERFAHREN ZUR IHRER HERSTELLUNG	⤷ Subscribe
Belgium	776958		⤷ Subscribe
Israel	38342	BIS(3,5-DIXOPIPERAZIN-1-YL)ALKANE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM	⤷ Subscribe
Germany	2163601		⤷ Subscribe
South Africa	7108200		⤷ Subscribe
Canada	1002049	3,5-DIOXOPIPERAZINYL DERIVATIVES	⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ZINECARD

Recent Clinical Trials for ZINECARD

Make Better Decisions: Try a trial or see plans & pricing